肝細胞癌に対するablation療法の治療成績

概要

論文の詳細を見る
We aimed to clarify the appropriate indication of the ablation therapy for hepatocellular carcinoma (HCC). Seventy-five patients treated for HCC in our department were divided into ablation group (ABL, n=10) and hepatectomy Group (n=65) by the initial treatment. Overall survival, disease free survival, and recurrence rate were compared. We also examined the therapeutic results for recurrent HCC (n=39). Treatment procedure, detail of the ABR recurrence patients (n=9) and survival were examined. There was no difference on survival. Recurrence rate was higher in ABL group. Of the recurrent patients in ABL group, 3 local recurrence patients received hepatectomy, and after that, re-recurrence did not occurred. Local control therapy was effective especially for multicentric carcinogenesis recurrent cases. In conclusion, ablation therapy is one of the good modality for HCC. But for high recurrence rate, the treatment strategy should be prudent.
特定非営利活動法人 Microwave Surgery研究会の論文